DCGI chief VG Somani gets three months extensionThe extension period will come to effect from November 11. This is the second extension that Somani got. His term was set to end on August ...
19 fixed-dose combinations drugs under radarThese cocktail drugs were licensed for manufacture and marketed by the state licensing authority. The 19 FDCs are commonly used for conditi...
Tenure of DCGI chief V G Somani extended by three monthsDr V G Somani to continue working as Drugs Controller General of India (DCGI) Chief for the next three months, according to an order issued...
DCGI claims India on course to become global drugs hubSpeaking at the Indian Drug Manufacturers' Association (IDMA) Annual Conclave, Somani said, "We are getting the applications of the investi...
Panel for removing penal provisions from proposed Drugs Act for lapsesThe existing Drugs and Cosmetics Act, 1940 is prosecutable. Any drug/cosmetic deemed to be adulterated or spurious is punishable with impri...
Pfizer, Moderna vaccines may soon be available in IndiaThe Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other inter...
Regulators told to ensure stocks of remdesivirDue to the spurt in demand, states like Madhya Pradesh ,Gujarat , Maharashtra are reporting shortage of the remdesivir injection, a key dru...
India extends shelf life of AstraZeneca vaccine: SourceThe approval, given to a licensed version of the drug made by the SII and exported to dozens of countries, could help health authorities mi...
DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situationThe subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.
India can expect a Happy New Year with Covid vaccines in hand: CDSCO, DGSomani’s statement on Thursday comes on the day Prime Minister Narendra Modi said India is making preparations for the largest adult immuni...
Trial volunteers given Rs 12 cr in compensation in the last 3 years: DCGIThe Drug Controller General of India (DCGI) on Friday said India had paid Rs 12 crore of compensation to clinical trial participants who ha...
Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?The DoP has asked the health ministry and drug regulatory authority to monitor if hospitals are prescribing the high-priced remdesivir wher...
Glenmark drops 5% as DCGI seeks clarity on Covid-19 drug, overpricing complaintsThe drug regulator also pulled up Glenmark over the pricing of the drug, after receiving a complaint from a member of Parliament.
DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFluDrug Controller General (India) VG Somani in a letter dated July 17 has asked for a clarification on the matter for taking necessary action.
Cipla and Hetero seek clinical trial waiver for RemdesivirWhile all new drugs must undergo trials before getting marketing approval in India, the regulator can grant exemptions in public interest a...
The reason why Indian doctors haven't prescribed Remdesivir yetThe US has given emergency approval to use the antiviral drug for the treatment of critical Covid-19 patients.
Faulty kits: Import licences of two Chinese companies canceledET had reported on Wednesday that more than a dozen importers held a valid licence to procure and import rapid testing kits from both the C...